As of 2025-07-07, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 20.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 103.40 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -80.6%.
The range of the Relative Valuation is (9.76) - 57.45 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.8x - 40.0x | 35.9x |
| Forward P/E multiples | 34.1x - 38.3x | 35.4x |
| Fair Price | (9.76) - 57.45 | 20.02 |
| Upside | -109.4% - -44.4% | -80.6% |
| Date | P/E |
| 2025-07-03 | -284.43 |
| 2025-07-02 | -276.81 |
| 2025-07-01 | -268.78 |
| 2025-06-30 | -259.18 |
| 2025-06-27 | -271.42 |
| 2025-06-26 | -265.06 |
| 2025-06-25 | -269.55 |
| 2025-06-24 | -271.20 |
| 2025-06-23 | -269.33 |
| 2025-06-20 | -263.58 |
| 2025-06-18 | -255.79 |
| 2025-06-17 | -255.08 |
| 2025-06-16 | -264.32 |
| 2025-06-13 | -267.10 |
| 2025-06-12 | -274.77 |
| 2025-06-11 | -287.48 |
| 2025-06-10 | -287.04 |
| 2025-06-09 | -282.94 |
| 2025-06-06 | -286.05 |
| 2025-06-05 | -274.50 |
| 2025-06-04 | -277.63 |
| 2025-06-03 | -275.41 |
| 2025-06-02 | -269.46 |
| 2025-05-30 | -276.78 |
| 2025-05-29 | -287.83 |
| 2025-05-28 | -283.52 |
| 2025-05-27 | -311.39 |
| 2025-05-23 | -302.17 |
| 2025-05-22 | -305.39 |
| 2025-05-21 | -308.00 |
| 2025-05-20 | -317.22 |
| 2025-05-19 | -326.10 |
| 2025-05-16 | -336.75 |
| 2025-05-15 | -333.80 |
| 2025-05-14 | -330.37 |
| 2025-05-13 | -349.18 |
| 2025-05-12 | -352.10 |
| 2025-05-09 | -340.65 |
| 2025-05-08 | -345.33 |
| 2025-05-07 | -330.89 |
| 2025-05-06 | -324.53 |
| 2025-05-05 | -326.05 |
| 2025-05-02 | -327.51 |
| 2025-05-01 | -317.44 |
| 2025-04-30 | -317.03 |
| 2025-04-29 | -322.83 |
| 2025-04-28 | -322.14 |
| 2025-04-25 | -320.41 |
| 2025-04-24 | -319.97 |
| 2025-04-23 | -315.02 |